Furthermore, CSF levels of another tau fragment, N-224, were significantly elevated in AD patients compared to individuals with mild cognitive impairment (MCI), subjective cognitive decline (SCD), and other neurodegenerative diseases, including PSP, PD, and MSA [31]. This evidence concerns the gene MAPT and Alzheimer disease.